Talarico D, Ittmann M, Balsari A, Delli-Bovi P, Basch R S, Basilico C
Department of Pathology, New York University School of Medicine, NY 10016.
Proc Natl Acad Sci U S A. 1990 Jun;87(11):4222-5. doi: 10.1073/pnas.87.11.4222.
The K-fgf/hst oncogene encodes a growth factor of the fibroblast growth factor (FGF) family that is secreted and transforms cells through a mechanism of autocrine cell proliferation. K-fgf-transformed cells are highly tumorigenic in immunocompetent allogeneic and syngeneic animals. BALB/c mice were immunized with a bacterial fusion protein consisting of a portion of the MS2 polymerase and of the human K-FGF precursor lacking only the first 4 amino acids or with a recombinant protein corresponding to the mature, secreted form of K-FGF (176 amino acids). They were then challenged with syngeneic K-fgf- or H-ras-transformed cells. Vaccinated animals exhibited a significant degree of protection against tumor induction, which was specific for K-fgf-transformed cells and correlated with the ability of the immunized mice to produce high titers of anti-K-FGF antibodies. Thus immunization with a single oncogene product can protect animals against tumor cells expressing this oncogene.
K-fgf/hst癌基因编码成纤维细胞生长因子(FGF)家族的一种生长因子,该生长因子可分泌,并通过自分泌细胞增殖机制使细胞发生转化。K-fgf转化细胞在具有免疫活性的同种异体和同基因动物中具有高度致瘤性。用一种细菌融合蛋白免疫BALB/c小鼠,该融合蛋白由MS2聚合酶的一部分和仅缺少前4个氨基酸的人K-FGF前体组成,或者用对应于K-FGF成熟分泌形式(176个氨基酸)的重组蛋白进行免疫。然后用同基因的K-fgf或H-ras转化细胞对它们进行攻击。接种疫苗的动物对肿瘤诱导表现出显著程度的保护作用,这种保护作用对K-fgf转化细胞具有特异性,并且与免疫小鼠产生高滴度抗K-FGF抗体的能力相关。因此,用单一癌基因产物进行免疫可保护动物免受表达该癌基因的肿瘤细胞的侵害。